Sugai Chemical Industry Co., Ltd. (TYO:4120)
Japan · Delayed Price · Currency is JPY 3,135.00
+55.00 (1.79%)
Aug 27, 2026, 9:00 AM JST
Sugai Chemical Industry Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 6,056 | 6,432 | 6,622 | 7,617 | 7,059 | 6,232 | |
Revenue Growth | -12.00% | -2.87% | -13.06% | 7.90% | 13.27% | 3.73% |
Cost of Revenue | 4,794 | 5,025 | 5,186 | 6,066 | 5,528 | 4,861 |
Gross Profit | 1,262 | 1,407 | 1,436 | 1,551 | 1,531 | 1,371 |
Selling, General & Admin | 851 | 831 | 813 | 833 | 806 | 744 |
Other Operating Expenses | 52 | 52 | 52 | 54 | 53 | 49 |
Operating Expenses | 938 | 918 | 895 | 913 | 880 | 811 |
Operating Income | 324 | 489 | 541 | 638 | 651 | 560 |
Interest Expense | -15 | -15 | -11 | -11 | -11 | -12 |
Interest & Investment Income | 84 | 71 | 57 | 51 | 50 | 37 |
Currency Exchange Gain (Loss) | 6 | 5 | 6 | 24 | 13 | 8 |
Other Non Operating Income (Expenses) | 17 | 15 | 21 | 27 | 40 | -4 |
EBT Excluding Unusual Items | 416 | 565 | 614 | 729 | 743 | 589 |
Gain (Loss) on Sale of Investments | - | - | -2 | - | 17 | - |
Gain (Loss) on Sale of Assets | 9 | 12 | 31 | 11 | 5 | - |
Asset Writedown | -16 | -18 | -27 | -16 | -29 | -26 |
Other Unusual Items | 75 | 74 | -85 | -255 | - | -80 |
Pretax Income | 484 | 633 | 531 | 469 | 736 | 483 |
Income Tax Expense | 140 | 172 | 168 | -20 | 158 | 79 |
Net Income | 344 | 461 | 363 | 489 | 578 | 404 |
Net Income to Common | 344 | 461 | 363 | 489 | 578 | 404 |
Net Income Growth | 21.13% | 27.00% | -25.77% | -15.40% | 43.07% | 27.45% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Change | 0.00% | - | - | -0.23% | -4.17% | -0.22% |
EPS (Basic) | 263.40 | 352.99 | 277.95 | 374.43 | 441.56 | 295.75 |
EPS (Diluted) | 263.40 | 352.99 | 277.95 | 374.43 | 441.56 | 295.75 |
EPS Growth | 21.13% | 27.00% | -25.77% | -15.20% | 49.30% | 27.73% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1,317 | -389 | 711 | 555 | 680 |
Free Cash Flow Per Share | - | 1008.42 | -297.86 | 544.41 | 423.99 | 497.80 |
Gross Margin | 20.84% | 21.88% | 21.68% | 20.36% | 21.69% | 22.00% |
Operating Margin | 5.35% | 7.60% | 8.17% | 8.38% | 9.22% | 8.99% |
Profit Margin | 5.68% | 7.17% | 5.48% | 6.42% | 8.19% | 6.48% |
Free Cash Flow Margin | - | 20.48% | -5.87% | 9.33% | 7.86% | 10.91% |
EBITDA | 830.5 | 985 | 995 | 1,102 | 1,112 | 1,017 |
EBITDA Margin | 13.71% | 15.31% | 15.03% | 14.47% | 15.75% | 16.32% |
D&A For EBITDA | 506.5 | 496 | 454 | 464 | 461 | 457 |
EBIT | 324 | 489 | 541 | 638 | 651 | 560 |
EBIT Margin | 5.35% | 7.60% | 8.17% | 8.38% | 9.22% | 8.99% |
Effective Tax Rate | 28.93% | 27.17% | 31.64% | - | 21.47% | 16.36% |